Pursuit Minerals Ltd (ASX: PUR) has signed a binding agreement to acquire 100% of Andara Mining Pty Ltd, securing rights over the Sascha–Marcelina Gold-Silver Project in the Deseado Massif, Santa Cruz, Argentina—one of the world’s premier epithermal belts. In parallel, the Company has received firm commitments of A$4.04 million to accelerate high-impact drilling across multiple walk-up targets.

Proteomics International Laboratories Ltd (ASX: PIQ) has been granted ISO 15189 certification for its Australian laboratory operations – a key milestone that cements its role as a leader in precision diagnostics. This certification validates the company’s systems, processes, and quality management, ensuring accurate and dependable clinical results.

OpenLearning Limited (ASX: OLL) has signed a five-year, usage-based SaaS agreement with Systems Plus College Foundation (SPCF), a comprehensive non-sectarian education provider in the Philippines. The partnership will see SPCF deploy OpenLearning’s AI-powered learning management system across all levels – from grade school to graduate programs.

Mesoblast Limited (ASX: MSB; Nasdaq: MESO) has highlighted the successful commercial launch of its flagship therapy, Ryoncil® (remestemcel-L-rknd), at two major global healthcare conferences — Morgan Stanley and Cantor Fitzgerald’s Annual Global Healthcare events in New York. This milestone underscores Mesoblast’s position as a global leader in allogeneic cellular medicines for inflammatory diseases.

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) has presented important data from its ATH434-201 Phase 2 clinical trial at the 150th Annual Meeting of the American Neurological Association (ANA) in Baltimore, USA. The trial focused on Multiple System Atrophy (MSA), a rare and rapidly progressive neurodegenerative disease. These results mark a significant milestone for Alterity as it moves closer to providing the first disease-modifying therapy for MSA.

Great Northern Minerals Ltd (ASX: GNM) has announced a significant expansion of its Catalyst Ridge REE–Antimony Project in the Mountain Pass District, California (Figure 1). The move marks a step-change in the Company’s U.S. footprint, adding new ground in one of the world’s most strategic rare earth corridors.

Golden Dragon Mining Ltd (ASX: GDR) is set to list on the ASX on 14 October 2025, following a fully subscribed IPO raising A$5 million at $0.20 per share. With a post-money market cap of A$8.89M and an enterprise value of just ~A$3.7M, GDR offers investors an attractive entry point into a multi-project gold explorer positioned in one of Western Australia’s most productive gold provinces.

Every so often, we see a project cross an important threshold – the point where years of technical work and regulatory engagement transform from planning into physical activity on the ground. For Alligator Energy Limited (ASX: AGE), the Samphire Uranium Project near Whyalla, South Australia, has reached exactly that point (Figure 1). With final regulatory approvals secured, drilling underway, and construction about to follow, the project is now positioned to generate the crit

DY6 Metals Ltd (ASX: DY6) is advancing exploration at its gallium and rare earth projects in southern Malawi, a move that comes at a time when global demand for critical minerals is intensifying. The upcoming sampling programs at Tundulu and Machinga are designed to build on high-grade results already reported, positioning the Company to unlock further value in strategically important commodities (Figure 1).

Terra Critical Minerals Limited (ASX: T92) has reported further high-grade silver mineralisation from its 100% owned Castle Rag Project in New South Wales (Figure 1). The latest results build on previously reported intercepts and continue to highlight the project’s potential within the broader New England mineral field.